Türkçe
Español
Injective’s price can benefit from changing market trends if INJ holders act on bullish signals. Buy signals continue to flash in the market, but the question of whether now is the right time to invest remains. Injective’s price is slowly trying to regain the profits it lost over the past few days.
What’s Happening with Injective?
Signs of this process also come from the Relative Strength Index (RSI). The RSI entered the oversold zone for the first time in four months, indicating potential for price recovery. Now, the RSI has shown an increase in the oversold zone. This change indicates that strong buying momentum is driving the price and setting the stage for a possible upward movement.
Additionally, DAA (Divergence Accumulation Analysis) data also signals a buy for INJ. This signal is typically supported by a significant increase in market participation, reflecting growing investor interest before positive price action. The increase in participation highlights growing confidence among investors, which is vital for sustaining price gains. As more investors join the network, the potential for continued price recovery strengthens.
Current indicators show a high likelihood that the price will benefit from ongoing investor enthusiasm and momentum. However, this is sustainable only if Injective’s price manages to break through significant resistance.
INJ Chart Analysis
Injective’s price at $16.2 is rebounding after nearly reaching an eight-month low of $14.1. The last time INJ was around this price was December 2023. Therefore, it is crucial for the altcoin to first break through the $18.5 resistance level and turn it into support. Doing so will provide the necessary support to initiate a sustainable recovery. A rise from the $18.5 support, along with potential accumulation, could push INJ towards $28.0.
Breaking this resistance is crucial to secure the rise, as a failed breakout in the past erased gains and sent the altcoin back to $18.5. If the same happens again, the bullish thesis will be invalidated as Injective’s price could fall to the $18.5 level.
